Redcliffe Labs launches mpox testing

Redcliffe Labs announced the launch of its advanced mpox testing capabilities, with the aim to reinforce national health security. Redcliffe Labs has a network of 80+ in-house labs, 2000+ collection centres, and a presence in 220+ cities. 

Mpox, a highly contagious viral disease increasingly recognised for its potential to cause localised outbreaks, poses significant public health risks if not detected and controlled promptly. With several cases reported in Africa, Europe, and parts of Asia, the urgency of this threat necessitates early preparedness and timely intervention to prevent the virus from spreading. 

Redcliffe Labs has assured key health authorities, including Noida’s Chief Medical Officer (CMO) and the Indian Council of Medical Research (ICMR), of its readiness to manage the mpox situation. Being prepared with advanced testing facilities not only ensures the rapid identification and isolation of cases but also guarantees that healthcare providers are fully equipped to handle increased demand. Additionally, it enables timely public communication and education, reducing misinformation and helping manage the community impact.